Handbook for high risk pregnancy : clinical management [E-Book]

"Nova Biomedical."

Includes bibliographical references and index.

Description based on print version record and CIP data provided by publisher.

HANDBOOK FOR HIGH RISKPREGNANCYCLINICAL MANAGEMENT; HANDBOOK FOR HIGH RISK PREGNANCY CLINICAL MANAGEMENT; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: OBSTETRIC RISK EVALUATION; INTRODUCTION; 1. RISK ASSESSMENT AT THE PRECONCEPTIONAL VISIT; 2. PRENATAL CARE: ON-GOING RISK EVALUATION; REFERENCES; Chapter 2: SPECIFIC FIRST TRIMESTER HIGH MATERNAL RISK: HYPEREMESIS GRAVIDARUM. PREVIOUS RECURRENT PREGNANCY LOSS. FIRST TRIMESTER BLEEDING; INTRODUCTION; REFERENCES; Chapter 3: DIABETES AND GESTATION; INTRODUCTION; DEFINITION; PREVALENCE; DIAGNOSIS; TREATMENT

INTRAPARTUM GLYCEMIC CONTROLPREVENTION; CONCLUSION; REFERENCES; Chapter 4: HYPERTENSION AND PREECLAMPSIA; 1. INTRODUCTION; 2. DEFINITIONS; 3. DEFINITIONS OF PREGNANCY-RELATEDHYPERTENSIVE DISORDERS; 4. EPIDEMIOLOGY; 5. ETIOPATHOGENESIS; 6. EARLY PREDICTION; 7. TREATMENT; 8. PREVENTION; REFERENCES; Chapter 5: PERINATAL INFECTIONS: LISTERIA, TOXOPLASMA, CYTOMEGALOVIRUS, HERPES AND HIV; INTRODUCTION; 1. LISTERIA MONOCYTOGENES; 2. TOXOPLASMA; 3. CYTOMEGALOVIRUS; 4. HERPES SIMPLEX; 5. HIV; REFERENCES; Chapter 6: UROLOGIC DISORDERS DURING PREGNANCY; INTRODUCTION; NEPHROLITHIASIS DURING PREGNANCY

URINARY TRACT INFECTIONS AND ASYMPTOMATIC BACTERIURIAIN PREGNANCYACUTE CYSTITIS; ACUTE PIELONEFRITIS; KIDNEY TRANSPLANTATION AND PREGNANCY; REFERENCES; Chapter 7: THROMBOPHILIA AND PREGNANCY; 1. INTRODUCTION; 2. THROMBOGENICITY OF THE PERIPARTUM PERIOD; 3. THROMBOPHILIAS; 4. LABORATORY TESTS (ACOG, 2010); 5. DISORDERS ASSOCIATED WITH THROMBOPHILIAS; 6. DIAGNOSTIC ALGORITHM IN SUSPECTED DEEP VEINTHROMBOSIS DURING PREGNANCY; 7. DIAGNOSTIC ALGORITHM IN SUSPECTED PULMONARY EMBOLISMDURING PREGNANCY; 8. CANDIDATES FOR THROMBOPHILIA EVALUATION (ACOG, 2010); 9. ANTICOAGULATION DURING PREGNANCY

10. MONITORING OF LOW MOLECULAR WEIGHTHEPARIN THERAPHY11. DURATION OF MAINTENANCE TREATMENT OFVENOUS THROMBOEMBOLISM; 12. DELIVERY AND ANTICOAGULANT TREATMENT; 13. POSTNATAL ANTICOAGULATION; REFERENCES; Chapter 8: AUTOIMMUNE DISORDERS; 1. INTRODUCTION; 2. SYSTEMIC LUPUS ERYTHEMATOUS (SLE)AND PREGNANCY; 3. ANTIPHOSPHOLIPID SYNDROME AND PREGNANCY; 4. OTHER AUTOINMUNE DISORDERS; REFERENCES; Chapter 9: LIVER DISEASES IN PREGNANCY; INTRODUCTION; PHYSIOLOGICAL CHANGES DURING GESTATION; HYPEREMESIS GRAVIDARUM; INTRAHEPATIC CHOLESTASIS OF PREGNANCY; ACUTE FATTY LIVER IN PREGNANCY; PRE-ECLAMPSIA

HELLP SYNDROMEHEPATIC HAEMATOMA, INFARCTION, AND RUPTURE; REFERENCES; Chapter 10: SPECIFIC DERMATOLOGICAL CONDITIONS; 1. PHYSIOLOGICAL CUTANEOUS CHANGES IN PREGNANCY; 2. SPECIFIC DERMATOSES OF PREGNANCY; 3. OTHER DERMATOSES AND INFECTIONS AFFECTEDIN PREGNANCY; REFERENCES; Chapter 11: THROMBOTIC MICROANGIOPATHY DURING PREGNANCY: THROMBOTIC THROMBOCYTOPENIC PURPURA DURING PREGNANCY; INTRODUCTION; EPIDEMIOLOGY AND PRESENTATIONS; PHYSIOPATHOLOGY; CLINICAL MANIFESTATIONS AND DIAGNOSIS; TREATMENT; REFERENCES; Chapter 12: NEUROLOGICAL DISEASE AND PREGNANCY; INTRODUCTION; 1. MIGRAINE; 2. EPILEPSY

There is a group of women that have a greater chance of pregnancy complications due to pre-existing health conditions or the occurrence of a specific disease related to pregnancy. Although some of these conditions are common, others have a low prevalence and the management raises a number of concerns to health care providers. This book, whose chapters have a similar structure focused on the clinical, diagnostic and therapeutic features will become an important tool to display the most appropriate clinical management in high risk cases.

Master record variable field(s) change: 050, 650